We are live on
!
Find out more
NCM
Neumann Capital Management Portfolio holdings
AUM
$151M
1-Year Est. Return
24.09%
This Fund
S&P 500
This Quarter
Est. Return
+3.66%
1 Year Est. Return
+24.09%
3 Year Est. Return
+79.39%
5 Year Est. Return
+87.97%
10 Year Est. Return
+267.54%
AUM
$153M
AUM Growth
–
Cap. Flow
+$151M
Cap. Flow
% of AUM
98.47%
Top 10 Holdings %
Top 10 Hldgs %
38.07%
Holding
86
New
86
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$7.62M |
| 2 |
Alerian MLP ETF
AMLP
|
+$6.27M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.03M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$5.83M |
| 5 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$5.82M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.01% |
| 2 | Technology | 10.41% |
| 3 | Financials | 8.21% |
| 4 | Industrials | 7.14% |
| 5 | Consumer Staples | 5.39% |
Similar funds
BA
DIG
MCCM
HEC
SHF
CCM
BDS
WBCM
Neumann Capital Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Neumann Capital Management, which disclosed 86 positions worth $153M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Gilead Sciences: 73,701 shares worth $6.95M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Technology and Financials.
- Neumann Capital Management's largest Q4 2014 buy was Gilead Sciences: 73,701 shares worth $6.95M.
- Neumann Capital Management's ten largest holdings make up 38% of its $153M portfolio in Q4 2014.
- Neumann Capital Management disclosed 86 positions in Q4 2014, its first 13F filing on record.
Based on Neumann Capital Management's 13F filing for Q4 2014, filed 2 Feb 2015.